X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics

Phase 3Positive

AI Analysis

Summary

Relay Therapeutics has initiated a Phase 3 clinical trial of a drug candidate identified through X-Chem's DNA-encoded chemical library screening technology, representing a key development milestone in their collaboration.

Clinical Trial Data

Phase

Phase 3

Outcome Details

Phase 3 clinical trial initiated

Importance:7/10

Sentiment:

0.60

Phase 3Clinical TrialCollaborationDrug DiscoveryDNA-encoded chemical library

Related Companies

$RLAY

Read the original article

Published by GlobeNewswire Clinical Studies on September 22, 2026 1:30 PM

Read Original